1. Home
  2. ITRG vs BNTC Comparison

ITRG vs BNTC Comparison

Compare ITRG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRG
  • BNTC
  • Stock Information
  • Founded
  • ITRG 1997
  • BNTC 1995
  • Country
  • ITRG Canada
  • BNTC United States
  • Employees
  • ITRG N/A
  • BNTC N/A
  • Industry
  • ITRG Precious Metals
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITRG Basic Materials
  • BNTC Health Care
  • Exchange
  • ITRG Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • ITRG 84.2M
  • BNTC 88.1M
  • IPO Year
  • ITRG N/A
  • BNTC N/A
  • Fundamental
  • Price
  • ITRG $1.20
  • BNTC $10.65
  • Analyst Decision
  • ITRG Strong Buy
  • BNTC Strong Buy
  • Analyst Count
  • ITRG 1
  • BNTC 5
  • Target Price
  • ITRG $3.75
  • BNTC $22.60
  • AVG Volume (30 Days)
  • ITRG 259.4K
  • BNTC 39.8K
  • Earning Date
  • ITRG 11-12-2024
  • BNTC 11-11-2024
  • Dividend Yield
  • ITRG N/A
  • BNTC N/A
  • EPS Growth
  • ITRG N/A
  • BNTC N/A
  • EPS
  • ITRG N/A
  • BNTC N/A
  • Revenue
  • ITRG N/A
  • BNTC N/A
  • Revenue This Year
  • ITRG N/A
  • BNTC N/A
  • Revenue Next Year
  • ITRG $360.53
  • BNTC N/A
  • P/E Ratio
  • ITRG N/A
  • BNTC N/A
  • Revenue Growth
  • ITRG N/A
  • BNTC N/A
  • 52 Week Low
  • ITRG $0.64
  • BNTC $2.69
  • 52 Week High
  • ITRG $1.28
  • BNTC $12.89
  • Technical
  • Relative Strength Index (RSI)
  • ITRG 66.49
  • BNTC 55.32
  • Support Level
  • ITRG $0.95
  • BNTC $10.70
  • Resistance Level
  • ITRG $1.28
  • BNTC $11.05
  • Average True Range (ATR)
  • ITRG 0.07
  • BNTC 0.74
  • MACD
  • ITRG 0.01
  • BNTC -0.02
  • Stochastic Oscillator
  • ITRG 77.27
  • BNTC 50.94

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Share on Social Networks: